{
    "eid": "2-s2.0-84938634555",
    "title": "Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment",
    "cover-date": "2015-08-15",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Microbiology (medical)",
            "@code": "2726"
        }
    ],
    "keywords": [
        "HIV",
        "kidney dysfunction",
        "tenofovir"
    ],
    "authors": [
        "Tim R. Cressey"
    ],
    "citedby-count": 13,
    "ref-count": 19,
    "ref-list": [
        "Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents",
        "VIREAD (Tenofovir Disoproxil Fumarate) Package Insert",
        "Tenofovir disoproxil fumarate: Clinical pharmacology and pharmacokinetics",
        "Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment",
        "The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients",
        "Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers",
        "The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards",
        "Quality Assurance Program for Clinical Measurement of Antiretrovirals: AIDS Clinical Trials Group Proficiency Testing Program for Pediatric and Adult Pharmacology Laboratories",
        "Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients",
        "Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir",
        "No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adults",
        "Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy",
        "Mechanism of active renal tubular efflux of tenofovir",
        "Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites",
        "Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir",
        "Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction",
        "HIV protease inhibitor ritonavir: A more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833",
        "Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens",
        "Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Boston",
            "affilname": "Harvard T.H. Chan School of Public Health",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Thai Red Cross Agency",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chiang Mai",
            "affilname": "Nakornping Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Omaha",
            "affilname": "College of Pharmacy",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": null,
            "affilname": "Chonburi Regional Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chiang Mai",
            "affilname": "Chiang Mai University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Marseille",
            "affilname": "Institut de Recherche Pour le Dveloppement UMI 174-Program for HIV Prevention and Treatment",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Chaing Mai",
            "affilname": "Sanpatong Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phayao",
            "affilname": "Phayao Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Institute of Allergy and Infectious Diseases"
    ]
}